TD-2749 is a is selective 5-HT4 agonist discovered by Theravance through the application of multivalent drug design in a drug discovery program dedicated to finding new medicines for GI motility disorders such as chronic constipation, constipation-predominant irritable bowel syndrome (C-IBS), opioid-induced constipation, functional dyspepsia and diabetic gastroparesis.
MedKoo Cat#: 462042
Name: TD-2749
CAS#: 863248-59-3
Chemical Formula: C26H38N6O2
Exact Mass: 466.3056
Molecular Weight: 466.63
Elemental Analysis: C, 66.92; H, 8.21; N, 18.01; O, 6.86
The following data is based on the product molecular weight 466.63 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
